ContextVision AB
OSE:CONTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (3.5), the stock would be worth kr5.28 (45% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.4 | kr3.64 |
0%
|
| 3-Year Average | 3.5 | kr5.28 |
+45%
|
| 5-Year Average | 5.2 | kr7.91 |
+117%
|
| Industry Average | 1.7 | kr2.55 |
-30%
|
| Country Average | 2 | kr2.98 |
-18%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
kr239.8m
|
/ |
Jan 2026
kr110.3m
|
= |
|
|
kr239.8m
|
/ |
Dec 2026
kr117.4m
|
= |
|
|
kr239.8m
|
/ |
Dec 2027
kr119.5m
|
= |
|
|
kr239.8m
|
/ |
Dec 2028
kr121.5m
|
= |
|
|
kr239.8m
|
/ |
Dec 2029
kr122.7m
|
= |
|
|
kr239.8m
|
/ |
Dec 2030
kr124.7m
|
= |
|
|
kr239.8m
|
/ |
Dec 2031
kr127.8m
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
|
ContextVision AB
OSE:CONTX
|
282.4m NOK | 2.4 | 338.1 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 9.7 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 5.4 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.4B USD | 8.3 | 29 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.5B AUD | 57.3 | 60.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 3 | 20.7 | |
| SE |
|
Sectra AB
STO:SECT B
|
50.6B SEK | 21.6 | 94.2 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 4.3 | 42.4 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 7 | 18.6 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 11.9 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
18.7B CNY | 8.7 | -60.8 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 1.2 |
| Median | 2 |
| 70th Percentile | 4.4 |
| Max | 13 940.4 |
Other Multiples
ContextVision AB
Glance View
ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 53 full-time employees. The firm's products are tailored primarily for medical imaging equipment manufacturers. Its product portfolio is structured into six groups, namely Mammography, comprising such products, as GOPView MAMMO, MAMMO PLUSViev and C-CAD; Ultrasound, comprising the US PlusView family of products, GOPView USXI and GOPiCE US products; Magnetic Resonance Imagining (MRI), comprising the GOPView MRI2 product; Computer tomography (CT), comprising the GOPView CT software; Digital X-Ray, comprising such products, as GOPView XR2 and GOPView XR2-DI, among others, and Interventional Radiology/Fluoroscopy, comprising the GOPView IRV Plus and GOPView IRV Ultra products. As of December 31, 2011, the Company had one wholly owned subsidiary, ContextVision Inc, based in the United States.
